Kopran Stock Screener | Share Price & Fundamental Analysis
KOPRAN
Pharmaceuticals
Share Price NSE
₹129.98
▼
-4.55 (-3.38%)
Share Price BSE
₹129.95
▼
-4.20 (-3.13%)
Track Kopran share price live with TickJournal's free stock screener.
Analyze Kopran share price history trends and compare 52-week high low
levels.
Calculate KOPRAN stock fair value using fundamental analysis and view live share price charts.
Determine Kopran share intrinsic value and compare it with current KOPRAN share price.
Record your Kopran trades in TickJournal's free trading journal and track your portfolio performance.
Kopran Market Cap
₹650.43 Cr.
KOPRAN P/E Ratio (TTM)
39.01
Kopran P/B Ratio
1.29
EPS (TTM)
₹7.99
Dividend Yield
2.24%
Debt to Equity
0.24
KOPRAN 52 Week High
₹205.85
Kopran 52 Week Low
₹123.24
Operating Margin
10.00%
Profit Margin
5.68%
KOPRAN Revenue (TTM)
₹176.00
EBITDA
₹20.00
Net Income
₹10.00
Total Assets
₹844.00
Total Equity
₹518.00
Kopran Share Price History - Stock Screener Chart
Screen KOPRAN historical share price movements with interactive charts. Analyze price trends and patterns.
Kopran Company Profile - Fundamental Screener
Screen Kopran company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for KOPRAN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE082A01010
Kopran Balance Sheet Screener
Screen KOPRAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 844 | 743 | 650 | 611 | 439 | 371 | 352 | 316 | 298 | 264 |
| Current Assets | 510 | 454 | 399 | 415 | 277 | 223 | 208 | 194 | 180 | 154 |
| Fixed Assets | 208 | 182 | 165 | 151 | 112 | 111 | 113 | 104 | 105 | 101 |
| Liabilities | ||||||||||
| Total Liabilities | 844 | 743 | 650 | 611 | 439 | 371 | 352 | 316 | 298 | 264 |
| Current Liabilities | 37 | 34 | 34 | 33 | 34 | 42 | 49 | 35 | 37 | 33 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 518 | 491 | 439 | 426 | 245 | 190 | 169 | 145 | 125 | 109 |
| Share Capital | 48 | 48 | 48 | 48 | 43 | 43 | 43 | 43 | 43 | 52 |
| Reserves & Surplus | 470 | 443 | 391 | 378 | 202 | 146 | 125 | 102 | 81 | 57 |
Kopran Income Statement Screener - Profit & Revenue Analysis
Screen Kopran income statement and profit fundamentals.
Analyze KOPRAN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Kopran share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 176 | 138 | 118 | 194 | 196 | 142 | 153 | 166 | 153 | 119 | 153 | 161 | 145 | 126 | 117 |
| Expenses | 155 | 121 | 123 | 177 | 164 | 121 | 137 | 146 | 137 | 111 | 130 | 135 | 117 | 113 | 107 |
| EBITDA | 20 | 17 | -5 | 18 | 31 | 21 | 16 | 20 | 16 | 9 | 23 | 26 | 28 | 14 | 11 |
| Operating Profit % | 10.00% | 10.00% | -4.00% | 9.00% | 12.00% | 13.00% | 10.00% | 12.00% | 8.00% | 5.00% | 15.00% | 15.00% | 18.00% | 10.00% | 9.00% |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Profit Before Tax | 14 | 10 | -12 | 11 | 25 | 15 | 10 | 14 | 11 | 4 | 18 | 21 | 24 | 10 | 6 |
| Tax | 4 | 2 | -2 | 1 | 7 | 4 | 2 | 4 | 3 | 1 | 5 | 5 | 7 | 2 | 1 |
| Net Profit | 10 | 7 | -10 | 9 | 19 | 11 | 7 | 10 | 8 | 3 | 14 | 16 | 18 | 8 | 5 |
| EPS | 2.01 | 1.54 | -2.06 | 1.93 | 3.86 | 2.30 | 1.53 | 2.16 | 1.67 | 0.58 | 2.86 | 3.28 | 3.68 | 1.58 | 0.97 |
Kopran Cash Flow Screener - Liquidity Fundamentals
Screen KOPRAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 42 | 43 | 34 | -34 | 60 | 31 | 25 | 26 | 16 | 29 |
| Investing Activities | -56 | -44 | -13 | -84 | -25 | -13 | -25 | -11 | -18 | -9 |
| Financing Activities | 26 | 1 | -20 | 123 | -35 | -18 | -1 | -15 | 2 | -19 |
| Net Cash Flow | 11 | 1 | 2 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Kopran Shareholding Pattern Screener
See Kopran shareholding pattern with promoter, FII, and DII holdings.
Check Kopran promoter holding and ownership changes for KOPRAN on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.42% | 44.42% | 44.42% | 44.42% | 44.49% | 44.49% | 44.49% | 44.46% |
| FII Holding | 1.12% | 0.76% | 0.60% | 0.36% | 0.84% | 0.68% | 1.32% | 0.86% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 1.20% | 0.14% | 0.22% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 41.36% | 42.83% | 44.65% | 44.71% | 37.98% | 39.69% | 40.74% | 41.35% |
| Other Holding | 13.10% | 11.99% | 10.33% | 10.51% | 15.49% | 15.01% | 13.23% | 13.32% |
| Shareholder Count | 58,652 | 60,194 | 62,222 | 60,886 | 50,850 | 51,492 | 57,154 | 60,560 |
Kopran Share Dividend Screener - Share Yield Analysis
Check Kopran dividend history with payout and yield data.
View Kopran dividend details including ex-dates and amounts for KOPRAN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹3.00 | 2.25% |
| 2024-March | ₹3.00 | 1.71% |
| 2023-March | ₹3.00 | 1.16% |
| 2022-March | ₹3.00 | 2.97% |
| 2021-March | ₹3.00 | 1.07% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Kopran Stock Index Membership
See which indices include Kopran stock.
Check KOPRAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Kopran Market Events Screener - Corporate Actions
Get Kopran corporate actions including splits, bonuses, and buybacks.
Check Kopran stock events that may affect KOPRAN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 3.00 /share | -10.35% | ||
| Dividend | ₹ 3.00 /share | 66.33% | ||
| Dividend | ₹ 3.00 /share | 18.17% | ||
| Annual General Meeting | NA | 26.71% | ||
| Annual General Meeting | NA | 2.79% | ||
| 2026-01-22 | 2026-01-22 | Quarterly Result Announcement | NA | -8.41% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -4.13% |
| 2025-07-29 | 2025-07-29 | Quarterly Result Announcement | NA | -1.94% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 7.28% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -0.98% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 0.67% |
| 2022-08-04 | 2022-08-08 | Dividend | ₹ 3.00 /share | -10.27% |
| 2021-08-05 | 2021-08-09 | Dividend | ₹ 1.50 /share | 6.33% |
Kopran Competitors Screener - Peer Comparison
Screen KOPRAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 410,406 | 37.23 | 54,729 | 9.71% | 10,980 | 53.25 |
| Divis Laboratories | 164,153 | 65.90 | 9,712 | 18.67% | 2,191 | 48.15 |
| Torrent Pharmaceuticals | 143,487 | 63.47 | 11,539 | 6.99% | 1,911 | 70.35 |
| Cipla | 108,653 | 24.16 | 28,410 | 7.12% | 5,291 | 45.95 |
| Dr Reddys Laboratories | 105,597 | 19.18 | 33,741 | 16.73% | 5,725 | 58.53 |
| Lupin | 102,556 | 21.74 | 22,910 | 13.74% | 3,306 | 60.82 |
| Zydus Life Science | 91,296 | 18.22 | 23,511 | 18.55% | 4,615 | 52.96 |
| Mankind Pharma | 85,583 | 47.66 | 12,744 | 20.90% | 2,007 | 45.43 |
| Aurobindo Pharma | 69,615 | 19.75 | 32,346 | 9.43% | 3,484 | 51.95 |
| Alkem Laboratories | 65,037 | 27.05 | 13,458 | 3.70% | 2,216 | 40.44 |
Kopran Company Announcements - News Screener
Screen KOPRAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-22 | Board Meeting Outcome for Results For Q3 FY 2025-26 | View |
| 2026-01-21 | Announcement Under Regulation 30 (LODR) | View |
| 2026-01-13 | Board Meeting Intimation for Results Of Q3 FY 2025-26 | View |
| 2026-01-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-01 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-12-26 | Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-23 | Closure of Trading Window | View |
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-10-30 | Board Meeting Intimation for Financial Result Q2 FY 2025-26 | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-18 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-15 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-15 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-11 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |